Background: Cigarette smoking is an independent risk factor for cardiovascular events such as myocardial infarction and stroke. To date, a useful and convenient method of predicting such events in smokers has not been established. The rheological properties of blood assessed by the microchannel method reflect the blood's viscosity and the state of microthrombus formation, which may predict cardiovascular thrombotic events.
lood rheology or fluidity, which is expressed as "viscous" or "non-viscous", reflects blood viscosity and the state of blood cells. Fluidity has been reported to be reduced (ie, viscosity is increased) in patients with lifestyle-related diseases such as hypertension. 1 Furthermore, reduced blood fluidity has been suggested to lead to cardiovascular thrombotic events such as myocardial and cerebral infarction. 2 The Micro Channel Array Flow Analyzer (MC-FAN) is an instrument that measures blood fluidity by a microchannel method using a capillary model. 3 This device analyzes the fluidity of blood passing a silicone-coated microchannel array according to its viscosity, microthrombus formation etc. The MC-FAN is superior to other methods in terms of accuracy and reproducibility, and evidence that it is markedly useful for the evaluation of blood fluidity and microcirculatory systems has accumulated. [4] [5] [6] Smoking is a major risk factor for cardiovascular diseases, associated with endothelial dysfunction, 7 but a decrease in blood fluidity in smokers or the effect of smoking cessation on viscosity has not yet been evaluated. Therefore, we measured blood fluidity in smokers, analyzed its correlation with various factors related to smoking, and examined whether quitting smoking improves fluidity. coagulant were excluded. Among 74 patients, 13 had received antihypertensive agents, 3 received statins, and 10 antidiabetic drugs. Blood fluidity was evaluated before and after quitting smoking in 17 patients who repeatedly visited the Smoking Cessation Clinic, National Hospital Organization, Kyoto Medical Center for more than 3 months during the study period and who successfully quit smoking.
Methods

Subjects
This study was performed after explaining the objective to the subjects in writing and obtaining their consent. It was performed with the approval of the Ethical Review Board, National Hospital Organization, Kyoto Medical Center.
Evaluation of Depression
The severity of depression was evaluated using a questionnaire based on the Self-rating Depression Scale (SDS). The questionnaire was answered by the patients, the answers were checked by the study staff, and the patients were asked to fill it in again if there were items that they had omitted or if mistakes had been made on answering. 8,9
Central Blood Pressure
The aortic pressure waves were estimated from pulse waves of the peripheral radial artery measured with an Omron HBM-9000AI and the augmentation index (AI) was determined as previously described. 10 
Blood Sampling and Evaluation of the Blood Fluidity
Blood was obtained from the patient's antecubital vein 2-3 h after lunch to determine hemoglobin A1c (HbA1c), low-density lipoprotein-cholesterol (LDL-C), and high-density lipoprotein-cholesterol (HDL-C) levels. The blood passage time (BPT) was measured with the MC-FAN HR300 rheometer (MC Lab.), as reported previously. 6,11 First, the microchannel passage time of 100 μl of physiologic saline was measured as a control, and then that of venous blood obtained from the patient with 5% heparinization was determined. The BPT of the patient was expressed after correction for the passage time of physiologic saline. A BPT exceeding 120 s was expressed as 120 s. 
Smoking Cessation Clinic
During the initial consultation, nicotine dependence was assessed with both the Fagerstrom Test for Nicotine Dependence (FTND) 12 and the Tobacco Dependence Screener (TDS). 13 In both tests, scores range from 0 to 10, with higher score indicating more severe nicotine dependence. The number of cigarettes smoked per day was determined by asking the smoker, "On average, in the past month, how many cigarettes did you smoke per day?". Smokers were asked to rate their confidence in their ability to abstain from smoking cigarettes in the next 3 months on a scale of 0-100%.
Anti-smoking treatment was conducted according to the Standard Procedures for Anti-Smoking Treatment (issued in March 2006 by the Japanese Circulation Society, Japan Lung Cancer Society, and Japanese Cancer Association). The patients were examined on their first visit and 2, 4, 8, and 12 weeks thereafter and treated with nicotine patches or oral varenicline. On their repeat visits, whether or not the patients had maintained smoking cessation was checked, and specific advice concerning the continuation of cessation was given. At the end of the anti-smoking treatment (after 12 weeks), whether or not cessation had been maintained was evaluated. A patient was judged to have succeeded in quitting smoking with an expiratory carbon monoxide concentration of 7 ppm or less and the patient's affirmation of not smoking. The attempt to quit smoking was judged to have been unsuccessful when the patient stopped visiting during the treatment period or continued visiting but failed to quit smoking.
Statistical Analysis
Data are presented as the mean ± SE, and P<0.05 was considered statistically significant. Statistical analyses were performed as previously described. 14 The correlations of blood fluidity with various parameters were examined according to Pearson's correlation coefficient. Factors that determine blood fluidity were analyzed using multiple logistic regression analysis. The blood fluidity values before and after quitting smoking were compared by the Mann-Whitney U-test. P<0.05 was regarded as significant.
Results
Correlations of BPT With Various Parameters in Patients Treated at the Smoking Cessation Clinic
The 74 subjects in this study who visited our Smoking Cessation Clinic consisted of 54 males and 20 females, with a mean age of 57.9±1.6 years. The mean male age was 61.9± 1.6 years, and the mean female age was 47.4±3.0 years. The duration of smoking at the initial examination was 37.5± 1.5 years, age at the beginning of regular smoking was 19.3± 0.5 years, number of cigarettes smoked per day was 26.0±1.3, FTND score was 7.3±0.2, Brinkman index was 953.8±65.5, TDS score was 8.4±0.2, degree of self-confidence to quit smoking was 42.3±3.8%, AI was 77.6±2.3%, and SDS score was 37.0±1.1.
The BPT showed significant positive correlations with the number of cigarettes smoked per day ( Figure 1A) , FTND score ( Figure 1B) , and Brinkman index ( Figure 1C) . It was also significantly correlated with the SDS test score (Figure 1D) , an index of depressive mood. However, the BPT showed no significant correlation with metabolic parameters such as body weight, systolic and diastolic blood pressures, HbA1c, LDL-C or HDL-C. There was no significant difference in the BPT between patients treated with (n=13, 70.9±8.2 s) and without (n=61, 66.5±3.9 s) antihypertensive agents, between patients treated with (n=3, 75.9±22.1 s) and without (n=71, 66.9±3.5 s) statins, or between patients taking (n=10, 68.1± 9.2 s) and those not taking (n=64, 67.1±3.8 s) antidiabetic agents. The SDS test score was significantly correlated with the FNTD score (r=0.658, P<0.001), TDS score (r=0.696, P<0.001) daily consumption of tobacco (r=0.528, P<0.001), duration of smoking (r=0.378, P<0.001), and Brinkman's index (r=0.375, P<0.001). On multivariate analysis using the BPT as the dependent variable, the number of cigarettes smoked per day was found to be an independent related factor (r=0.326, P=0.045) ( Table 1) . 
Changes in the BPT in Patients Who Successfully Quit Smoking
The 17 patients who successfully quit smoking on outpatient treatment in this study consisted of 16 males and 1 female, with a mean age of 61.5±2.7 years. The initial prescription was nicotine patches (Nicotinell TTS) in 6 and varenicline (Champix) in 11, but the nicotine patch therapy was changed to varenicline during the course of treatment in 1 patient. Body weight significantly (P<0.05) increased from 69.5± 3.1 kg at the beginning to 70.9±3.1 kg at the end. The BPT significantly shortened from the initial examination to the end of the 3-month period of insured treatment (63.0±4.5 to 49.7± 2.0 s, P=0.002) (Figure 2) . The improvement was marked in patients with an initial BPT of 50 s or longer (n=12, 70.3±5.1 to 52.3±3.5 s, P=0.002), but was unremarkable and non-significant in those with an initial BPT shorter than 50 s (n=5, 45.5±1.2 to 43.5±5.7 s, P=0.450). The BPT did not improve in patients who were unsuccessful in ceasing smoking (n=3, 77.3±22.9 to 91.7±28.3 s). Changes in the BPT were compared according to the treatment. A patient who could not quit smoking on nicotine patch treatment but successfully quit on varenicline administration was included in the varenicline group. At the initial examination, the BPT tended to be longer in the varenicline group (n=11, 68.6±6.1 s) than in the nicotine patch group (n= 6, 52.8±4.1 s) (P=0.097). In the varenicline group, the BPT decreased significantly from before to after quitting smoking (68.6±6.1 to 52.0±2.7 s, P=0.007). In the nicotine patch group, it also decreased after quitting smoking, although not significantly (52.8±4.1 to 45.4±2.0 s, P=0.182).
Discussion
Reduced blood fluidity has been suggested to lead to thrombotic events, such as cerebral and myocardial infarction, which are the most serious complications of lifestyle-related diseases. 1,2 Analysis using the MC-FAN has revealed that blood viscosity increases when cardiovascular risk factors such as hypertension, dyslipidemia, and obesity are present. 3-5 We have also reported that blood viscosity increases markedly in patients with metabolic syndrome and decreases with weight reduction. 6 However, there has been no detailed analysis using the MC-FAN of reduced blood fluidity (ie, increased blood viscosity) in smokers. In this study, the BPT was significantly correlated with the number of cigarettes smoked per day, FTND score, and Brinkman index in patients who initially visited the Smoking Cessation Clinic. Also, multivariate analysis showed that the number of cigarettes smoked per day was a determinant of the BPT. From these observations, smoking is considered to be clearly related to an increase in blood viscosity.
Women's blood viscosity may alter before and after menopause. Unfortunately, we do not have information on the menstrual status of the female patients in the present study. Furthermore, the number of women (n=20) in our study population did not appear to be sufficient to analyze differences 
and female (n=20, 59.2±6.1 s) patients, or between female patients above (n=10, 53.4±7.7 s) and below (n=10, 65.1±9.6 s) the age of 50, at which menopause occurs on average. However, further studies are needed on the affect of sex and menstrual status on blood viscosity. Nevertheless, analysis of the total population including both sexes clearly indicated a close association between smoking-associated variables and the BPT. Thus, the suggestion of a close association between smoking and increased blood viscosity may be valid.
In our clinic, when the score of the SDS test is in the range of major depression (>60), we always consult psychiatrists before starting smoking cessation therapy. However, the SDS test score of smoking patients in the present study ranged from 21 to 59, and no patient showed a score above 60. These findings suggest that the patients in this study were not in the "diseased state of major depression", but in a "latent depressive state". We previously reported that the incidence of latent depression was high in smokers even without a clear history of psychiatric disorders. 8 Interestingly, an increase in blood viscosity was also significantly correlated with the SDS test score, which is an index of depression. Details of the mechanism of the relationship of depression with a low blood fluidity are unknown. Patients with depression or latent depression show a marked dependence on smoking and have difficulty in quitting. 9 The present study demonstrates that the SDS test score was significantly correlated with nicotine dependency and number of cigarettes smoked by patients. The correlations of the SDS score with smoking variables suggest that a latent depressive state significantly contributes to a high blood viscosity (reduced blood fluidity) caused by cigarette smoking. However, these data do not rule-out the possibility that a latent depressive state is directly involved in reduced blood fluidity. Type A characteristics are a wellknown risk factor for cardiovascular events such as myocardial infarction and stroke. Further evaluation is necessary to clarify whether or not a latent depressive state is directly associated with reduced blood fluidity.
The BPT was significantly shortened in patients who successfully quit smoking after 3 months of anti-smoking treatment. The shortening was more marked in patients who showed a higher blood viscosity at the initial examination. An early improvement in blood fluidity after the onset of anti-smoking treatment may suggest an early decrease in cardiovascular risk. The BPT was shortened in patients treated with varenicline and those treated with nicotine patches. However, shortening was marked and significant in the former group but was not significant in the latter. Varenicline can be used more safely than nicotine patches in patients with cerebral or myocardial infarction. At our hospital, varenicline is used as the first choice for smoking cessation therapy in patients with a high cardiovascular risk, such as those with a history of cerebral or myocardial infarction. In addition, when smoking patients exhibit relatively higher amounts of tobacco consumption, we preferentially choose varenicline rather than a nicotine patch. In fact, the number of cigarettes smoked per day tended to be larger in the present varenicline group (25.0±11.3) than in the nicotine patch group (19.7± 0.8). The BPT tended to be longer in the varenicline group than in the nicotine patch group at the initial examination. A relatively high consumption of tobacco in the varenicline group may have contributed to a longer BPT in this group at baseline. The shortening of the BPT after quitting smoking is considered to have been essentially related to quitting smoking itself, but a direct effect of varenicline on blood fluidity cannot be excluded.
Blood fluidity was closely correlated with factors related to smoking and was improved by quitting. Evaluation of blood fluidity using the MC-FAN is not only highly reproducible but the device also enables visual observation of blood passing through the microchannels. Thus many of the smokers realized that their blood was viscous, which renewed their motivation to quit smoking. This study suggests the usefulness of blood fluidity as an index of cardiovascular event risk in smokers, an index of the effectiveness of anti-smoking treatment, and as a tool to encourage patients to quit smoking.
